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Objective
To assess the diagnostic accuracy of CMR scans in predict-
ing future major cardiovascular adverse events in patients
with suspected arrhythmogenic right ventricular cardio-
myopathy (ARVC).
Background
ARVC is a genetic disease that affects young patients prone
to sudden cardiac death. The incomplete penetrance of
this disorder with variable age of onset means there is a
large heterogeneity in the clinical expression of the disease
with strikingly different phenotypes. It is therefore crucial
to identify within a population with suspected ARVC, a
subset who will definitely have a higher susceptibility of
developing the disease, and thus be at an increased risk of
major adverse cardio-vascular events (MACE).
Methods
We studied 379 consecutive patients referred for CMR
examinations with suspected ARVC based on at least one
minor criterion as defined by the Task Force Criteria,
between 2002 and 2005. Patients were divided into 2
groups depending on their initial scan results: "normal"
or "abnormal". The latter was defined as either increased
RV end-diastolic volume, and/or decreased RV ejection
fraction, and/or RV regional wall motion abnormality,
and/or the presence of late gadolinium enhancement in
the LV and/or RV. Cut-off values for normal versus abnor-
mal volumes and ejection fraction were based on previ-
ously published reference ranges indexed for BSA and
adjusted for age, from our institution. Follow-up data was
obtained for all patients in 2009 and reviewed by two
independent researchers. MACE were defined as all cause-
mortality, occurrence of life-threatening arrhythmias,
appropriate ICD discharge, and unplanned hospital
admission for cardiovascular events. Positive and negative
predictive values of abnormal and normal scans for MACE
were calculated.
Results
223 patients (59%) had normal baseline scans. Both
groups were well matched in their clinical presentations
(VT episodes, unexplained syncope, family history includ-
ing sudden cardiac death). Patients with abnormal scans
were older (47.4 yrs ± 14.5) and more often male (64.1%)
than those with normal scans (40.9 yrs ± 16.1, 44.8%
males). The overall negative predictive value of a normal
scan for MACE was 89%; the positive predictive value of
an abnormal scan was 19%. This was statistically signifi-
cant (p = 0.032), translating into an odds ratio for an
abnormal scan of 1.89 (95% CI 1.05-3.40) in predicting
MACE.
Conclusion
The data confirm the value of CMR in a "real-life" patient
population referred for suspected ARVC. A normal CMR
scan, regardless of whether the diagnosis of ARVC is con-
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firmed or not, allows to reliably predict a long-term major
cardiovascular event-free outcome.Page 2 of 2
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